ANZ cleared of rate fixing

The company has come under the microscope for interest rates before, but this time it's different.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ANZ (ASX: ANZ) is heralded as Australia's most profitable bank for its size, constantly having the best return on equity out of any of the big four for domestic lending, however its overseas operations have just proved to be costly. ANZ decided to keep interest rates on hold last week, which was unsurprising given the RBA's decision, but perhaps domestic interest rates aren't the only thing to be worried about.

On Friday, the Monetary Authority of Singapore (MAS) alleged some of Australia's banks have been implicated in an interest rate rigging scandal which has resulted in ANZ and Macquarie (ASX: MQG) being liable to set aside an extra S$100 million to S$300 million in reserves.

Although MAS said that the actions did not produce any conclusive evidence that the rates were successfully manipulated, it did say that "a number of traders at banks lacked professional ethics". UBS (NYSE: UBS) and Royal Bank of Scotland (FTSE: RBS) were forced to set aside between S$1 billion and S$1.2 billion.

ANZ has said a number of employees were engaged in "inappropriate" behaviour and "disciplinary action has been taken with a small number of staff".

The results and consequences will have no impact on ANZ's Singapore operations but has changed its rate setting process and training standards as a result.

Foolish takeaway

ANZ's 'Super Regional Strategy' is what sets it apart from its domestic rivals like NAB (ASX: NAB) and the Commonwealth Bank (ASX: CBA) but it still has challenges ahead of it. Domestically, it remains the most competitive bank despite having one of the lowest interest rate mortgages out of the big four. Investors who are seeking growth, income and security could do worse than ANZ, particularly as the company's stock price has dropped over 10% in recent weeks – perhaps it's time to grab a bargain.

In the market for high yielding ASX shares? Get "3 Stocks for the Great Dividend Boom" in our special FREE report. Click here now to find out the names, stock symbols, and full research for our three favourite income ideas, all completely free!

More reading


Motley Fool contributor Owen Raszkiewicz does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »